Kharkiv City Clinical Hospital No.2 n.a. Prof. O.O. Shalimov /ID# 165657

Kharkiv 61037

0 studies enrolling now · 1 studies all time

What they study most

Crohn's Disease

Studies at this site

• A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease — Running, not enrolling